EP4069254
FAST SKAMMTAFORM TIL INNTÖKU SEM INNIHELDUR DESÍTABÍN OG SEDASÚRÍDÍN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.2.2021EP published:
11.9.2024EP application number:
21761883.4
EP translation filed:
17.9.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
23.2.2041Expiry date:
23.2.2027Next due date:
28.2.2027
Title in English:
SOLID ORAL DOSAGE FORMS COMPRISING DECITABINE AND CEDAZURIDINELanguage of the patent:
English
Timeline
Today
24.2.2021EP application
11.9.2024EP Publication
17.9.2024Translation submitted
15.10.2024Registration published
23.2.2027Expires
Owner
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535, JP
Inventor
Name:
OGANESIAN, AramAddress:
Dublin, California 94568, US
Name:
DAVAR, NipunAddress:
Pleasanton, California 94566, US
Name:
KOU, Jim HwaicherAddress:
San Jose, California 95129, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
202062981304 PDate:
25.2.2020Country:
US
Classification
Categories:
A61K 31/706, A61K 31/7068, A61P 35/00, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 16.1.2025
Expires: 23.2.2026
Payer: Árnason Faktor ehf.
Number: 6
Paid: 16.2.2026
Expires: 23.2.2027
Payer: Árnason Faktor ehf.